Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies

ConclusionsOur findings demonstrate clinical utility and feasibility of integrating a NGS-based gene mutation and fusion testing assay as a frontline diagnostic test in a large reported cohort of patients with suspected myeloid malignancy, in a clinical laboratory setting. Overlap with cytogenetic test results provides opportunity for testing reduction and streamlining.

http://link.springer.com/10.1007/s40291-022-00581-7

Source: Molecular Diagnosis and Therapy - April 5, 2022 Category: Molecular Biology Source Type: research